MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Differences in gray matter atrophy and functional connectivity between motor subtypes of Parkinson’s disease

    L. Yin, J. Fu, Z. Xu (kunming, China)

    Objective: This study compared gray matter volume (GMV) and functional connectivity among patients with Parkinson’s disease involving postural instability/gait difficulty (PD-PIGD), patients with tremor-dominant Parkinson’s disease (PD-TD) and healthy…
  • 2023 International Congress

    Prevalence of depression and cognitive impairment in a Hungarian Parkinson’s disease Center

    EK. Balogh, E. Balogh, A. Mező, M. Bokor (Budapest, Hungary)

    Objective: Our aim is to determine the prevalence of depression and cognitive impairment (CI) among our PD patients. Background: Depression and CI are the most…
  • 2023 International Congress

    Laryngeal clinical biomarkers in atypical Parkinsonism – results from an international multicenter study

    F. Gandor, A. Vogel, L. Berger, D. Gruber, I. Claus, P. Corelli, G. Giannini, N. Madetko-Alster, G. Höglinger, M. Klietz, C. Schrader, B. Falkenburger, T. Shimohata, K. Kunieda, J. Kassubek, R. Kassubek, MJ. Marti, G. Wenning, A. Fanciulli, C. Pototschnig, T. Gurevich, Y. Manor, HJ. Kim, D. Weise, P. Urban, R. Dziewas, T. Warnecke (Beelitz-Heilstätten, Germany)

    Objective: To investigate the prevalence of laryngeal motion abnormalities in patients with atypical Parkinsonism. Background: Using a previously published FEES task-protocol[1-3], we identified irregular involuntary…
  • 2023 International Congress

    Clinical implication of small vessel disease burden on deep brain stimulation outcome in Parkinson’s disease

    J. Lee, S. Jo, S. Lee, MS. Kim, SJ. Chung (Seoul, Republic of Korea)

    Objective: We aimed to investigate the correlation between the small vessel disease (SVD) burden and the 1-year outcome after the globus pallidus interna (GPi) deep…
  • 2023 International Congress

    Gut microbiota dysbiosis in Parkinson’s disease patients: a potential biomarker of disease severity and progression?

    R. Cerroni, M. Conti, M. Pierantozzi, V. D'Angelo, N. Mercuri, A. Teofani, D. Pietrucci, G. Chillemi, V. Unida, A. Stefani (Rome, Italy)

    Objective: To investigate gut microbiota alterations in Parkinson's disease (PD) along disease progression. Background: Gut microbiota dysbiosis is considered a hallmark in PD1. However, it is…
  • 2023 International Congress

    Identification of ZYIL1, a novel NLR family pyrin domain containing 3 protein inhibitor: a potential disease modifier in Parkinson’s disorder

    A. Chatterjee (Ahmedabad, India)

    Objective: Identification and evaluation of the potential of a novel NLR family pyrin domain containing 3 (NLRP3) inflammasome inhibitor (ZYIL1) as a Parkinson’s disease (PD)…
  • 2023 International Congress

    A strategic training framework for building research capacity in the Global Parkinson’s Genetics Program (GP2)

    MT. Periñan, S. Dey, C. Bale, M. Kuhl, H. Leonard, P. Lewis, S. Stott, MB. Makarious, A. Martinez-Carrasco, AJ. Noyce, S. Bandres-Ciga, GP2. Genetics Program (Seville, Spain)

    Objective: To promote and facilitate learning internationally with resources and expertise to serve the training needs of the Global Parkinson’s Genetics Program (GP2;www.gp2.org) and its…
  • 2023 International Congress

    Clinical and genetic analyses of a Swedish patient series diagnosed with ataxia

    S. Gorcenco, E. Kafantari, J. Wallenius, C. Karremo, E. Alinder, S. Dobloug, M. Landqvist Waldö, E. Englund, H. Ehrencrona, K. Wictorin, K. Karrman, A. Puschmann (Lund, Sweden)

    Objective: In this study, we aimed to examine clinically and genetically a patient series with ataxia from southern Sweden with known or unknown genetic causes.…
  • 2023 International Congress

    Development and Evaluation of a Digital Resource Library for Arkansans with Parkinson Disease and Their Caregivers

    S. Dhall, A. Diamond, T. Virmani, R. Sloan, T. Burrow, J. Chacko, C. Fullen, T. Reckling, J. Holton, H. Pickett, H. Petersen, K. Coleman, D. Mcclendon, D. Chandler, E. Echols, C. Gauss, K. Donovan, S. Parveen, R. Dhall (Little Rock, USA)

    Objective: To develop and evaluate impact of a Digital Resource Library (DRL) to address unmet needs for disease state education of People with PD (PwP)…
  • 2023 International Congress

    The prevalence of delirium and subsequent outcomes in inpatients with Parkinson’s disease

    F. Gerakios, G. Bate, L. Wright, D. Davis, B. Stephan, L. Robinson, C. Brayne, L. Barnes, G. Stebbins, JP. Taylor, D. Burn, L. Allan, A. Yarnall, S. Richardson, R. Lawson (Newcastle Upon Tyne, United Kingdom)

    Objective: To report delirium prevalence in hospitalised Parkinson’s disease (PD) participants compared to older adults and examine the association with mortality in a prospective study.…
  • « Previous Page
  • 1
  • …
  • 241
  • 242
  • 243
  • 244
  • 245
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley